Novo Integrated Sciences Inc. (NVOS): What is the Risk Factor?

Novo Integrated Sciences Inc. (NASDAQ:NVOS) saw a downside of -13.61% to close Monday at $0.09 after subtracting -$0.02 on the day. The 5-day average trading volume is 3,856,980 shares of the company’s common stock. It has gained $0.1128 in the past week and touched a new high 1 time within the past 5 days. An average of 3,709,070 shares of the company has been traded in the last 20 days, and the 50-day average volume stands at 4,623,272.

NVOS’s 1-month performance is -33.14% or -$0.0450 on its low of $0.0876 reached on 08/07/23. The company’s shares have touched a 52-week low of $0.10 and high of $1.91, with the stock’s rally to the 52-week high happening on 01/09/23. YTD, NVOS has lost -54.85% or -$0.1103 and has reached a new high 2 times. However, the current price is down -95.25% from the 52-week high price.

Top 5 AI Stocks to Buy for 2023

The artificial intelligence (AI) revolution is already here. And it's about to change everything we know about everything. According to Grand View Research, the global AI boom could grow from about $137 billion in 2022 to more than $1.81 trillion by 2030. And investors like you always want to get in on the hottest stocks of tomorrow. Here are five of the best ways to profit from the AI boom.

Click Here to Download the FREE Report.

Sponsored

Valuation Metrics

NVOS stock has a beta of -0.18. Moving on to other valuation ratios, the trailing price-to-sales (P/S) ratio is 11.85 while the price-to-book (PB) in the most recent quarter is 0.48.

Novo Integrated Sciences Inc.’s quick ratio for the recent period was 0.50, with the current ratio over the same period at 0.60. The firm’s gross profit as reported stood at $4.8 million against revenue of $11.74 million.

Earnings Surprise

Net income and sales went up compared to those figures reported in the previous quarter. Net income shrunk -220.67% to -$1.5 million, while revenue of -$3.94 million was -162.67% off the previous quarter. EBITDA for the quarter stood at more than -$0.69 million. NVOS stock balance sheet for the recent quarter shows that total liabilities totaled 9.45 million, with total debt at $4.58 million. Shareholders hold equity totaling $148.43 million.

Let’s look briefly at Novo Integrated Sciences Inc. (NVOS) price momentum from a technical analysis perspective. The 9-day relative strength index as at close on 07 August was 21.73% to suggest the stock is trending oversold, with historical volatility in this time period at 87.05%.

The stock’s 5-day moving average is $0.1037, reflecting a -13.77% or -$0.0145 change from its current price. NVOS is currently trading -32.99% above its 20-day SMA, -27.19% above its 100-day SMA. However, the stock’s current price level is away from the SMA50 by -39.55% and SMA200 by-69.23%.

Stochastic %K and %D was 14.78% and 16.13% and the average true range (ATR) pointed at 0.0091. The RSI (14) points at 27.92%, while the 14-day stochastic is at 9.04% with the period’s ATR at 0.0096. The stock’s 9-day MACD Oscillator is pointing at -0.0065 and -0.0093 on the 14-day charts.

Analyst Ratings

Most Popular

Related Posts